Antidote Therapeutics, Inc. reported raising $200,000 in an initial SEC Form D filing, from an offering of $200,000
Amount Raised
$200,000
Round Type
Seed
GaithersburgBiotechnologyWho else raised in Biotechnology around the same time
Companies in the same sectors as Antidote Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- SILK TECHNOLOGIES, LTD. raised $5M on October 26, 2017.
- EmboMedics, Inc. raised $741K (Seed) on October 25, 2017.
- Helixbind, Inc. raised $2.9M (Seed) on October 24, 2017.
- GeneCapture raised $55K (Pre-Seed) on October 23, 2017.
- Portal Instruments, Inc. raised $6M on October 20, 2017.
- Kineta, Inc. raised an undisclosed amount on October 20, 2017.
Who to call at Antidote Therapeutics, Inc., and when
A new round usually means Antidote Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Antidote Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Antidote Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Antidote Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Antidote Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Antidote Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.